Loading
journalsJournal
Radiotherapy and Oncology
ESTRO's journal, known as the Green Journal: European radiotherapy trials, contouring guidelines, physics and the evidence base for hypofractionation and proton therapy.
Also called: Radiother OncolThe Green Journal
Overview
Radiotherapy and Oncology (Radiother Oncol), known as the Green Journal, is the journal of the European Society for Radiotherapy and Oncology (ESTRO), founded in 1983 and published by Elsevier on a hybrid access model. It publishes ESTRO consensus contouring guidelines, randomised radiotherapy trials, normal-tissue toxicity modelling, adaptive and image-guided radiotherapy studies, physics and health-economic analyses of radiotherapy access in Europe, and the evidence base for hypofractionation and proton therapy. Its readers are radiation oncologists, medical physicists and trialists. Within OnCo it is linked from the FLASH radiotherapy entry and the Jens Overgaard and Jean Bourhis biographies, and it is the place to look for European radiotherapy trials and contouring consensus.
Publisher
Elsevier · European Society for Radiotherapy and Oncology
Scope
radiation oncology
Website
Access model
hybrid
Founded
1983
ISSN
0167-8140
observational20237 citations
Seed-displacements in the immediate post-implant phase in permanent prostate brachytherapy
One cancer page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
observational2021169 citations
Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan ( 10 B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial
One technology page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
review2020508 citations
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
One term page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
observational2019512 citations
Treatment of a first patient with FLASH-radiotherapy
One technology page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
review2014381 citations
Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012
One bottleneck page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
rct1998410 citations
A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85
One trial page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
Barbara Jereczek-Fossa
President
Radiation oncologyProstate cancer radiotherapyStereotactic radiotherapy
Milan radiation oncologist leading ESTRO, Europe's radiotherapy and oncology society.
Claus Belka
Director, Department of Radiation Oncology, LMU Munich
Radiation oncologyMR-guided radiotherapyRadiobiology
Claus Belka is a radiation oncologist leading MR-guided adaptive radiotherapy research in Munich.
Eric Felix Lartigau
Representative of Centre Oscar Lambret to the Organisation of European Cancer Institutes
Cancer centre representation (OECI)
Eric Felix Lartigau represents Centre Oscar Lambret in the Organisation of European Cancer Institutes, which lists the centre among its members in France.
Jean Bourhis
Head of Radiation Oncology, Lausanne University Hospital (CHUV)
Head and neck radiotherapyMeta-analysisAltered fractionation
Radiation oncologist behind the MACH-NC meta-analyses that proved chemoradiotherapy helps head and neck cancer, and the first FLASH-treated patient.
Jens Overgaard
Professor, Department of Clinical Medicine - The Department of Oncology
Radiation oncologyHead and neck cancerTumour hypoxia
Pioneering radiation oncologist at Aarhus who led the DAHANCA trials on hypoxia modification and radiotherapy for head and neck cancer.
Julian Malicki
Representative of Greater Poland Cancer Centre to the Organisation of European Cancer Institutes
Cancer centre representation (OECI)
Julian Malicki represents Greater Poland Cancer Centre in the Organisation of European Cancer Institutes, which lists the centre among its full members in Poland.
Martin Jan Schalij
Chair of the Executive Board
CardiologyHospital leadership
Cardiologist who chairs the Executive Board of Leiden University Medical Center.
Matthias Guckenberger
Past-President
Stereotactic body radiotherapyOligometastatic diseaseLung cancer radiotherapy
Zurich radiation oncologist and ESTRO Past-President, a leading voice on stereotactic radiotherapy for oligometastases.
Michael Baumann
Chairman and Scientific Director, German Cancer Research Center (DKFZ)
Radiation oncologyRadiobiologyResearch leadership
Michael Baumann is a radiation oncologist who leads Germany's national cancer research centre.
Nikolaos Zamboglou
Representative of German Oncology Center to the Organisation of European Cancer Institutes
Cancer centre representation (OECI)
Nikolaos Zamboglou represents German Oncology Center in the Organisation of European Cancer Institutes, which lists the centre among its members in Cyprus.
Renaud de Crevoisier
Directeur Général (Director General), Centre Eugène Marquis
OncologyCancer centre managementAcademic medicine
Professor of medicine who directs Centre Eugène Marquis, the regional comprehensive cancer centre for Brittany in Rennes.
Vincenzo Valentini
Professor of Radiation Oncology, Università Cattolica; Gemelli
Radiation oncologyRectal cancerPredictive modelling
Vincenzo Valentini is a radiation oncologist known for rectal cancer chemoradiation and outcome modelling.
observationalRadiotherapy and Oncology 20237 citations
Seed-displacements in the immediate post-implant phase in permanent prostate brachytherapy
One cancer page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
observationalRadiotherapy and Oncology 2021169 citations
Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan ( 10 B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial
One technology page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
reviewRadiotherapy and Oncology 2020508 citations
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
One term page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
observationalRadiotherapy and Oncology 2019512 citations
Treatment of a first patient with FLASH-radiotherapy
One technology page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
reviewRadiotherapy and Oncology 2014381 citations
Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012
One bottleneck page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
rctRadiotherapy and Oncology 1998410 citations
A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85
One trial page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
Similar pages
technologies
people
key papers
A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan ( 10 B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trialDefining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus documentEstimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012Seed-displacements in the immediate post-implant phase in permanent prostate brachytherapyTreatment of a first patient with FLASH-radiotherapy